A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer
Title:
A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer
Author:
Cristofanilli, Massimo Johnston, Stephen R. D. Manikhas, Alexey Gomez, Henry L. Gladkov, Oleg Shao, Zhimin Safina, Sufia Blackwell, Kimberly L. Alvarez, Ricardo H. Rubin, Stephen D. Ranganathan, Sulabha Redhu, Suman Trudeau, Maureen E.